This article deconstructs three examples of unsubstantiated talking points used in support of the vaccines and chronic diseases argument.

Target gene could serve as the basis of a future therapeutic intervention.

The study identified obstacles like limited time during clinical visits, a lack of comprehensive resources, and insufficient notice from caregivers to prepare for discussions.

In a landmark study, an international consortium led by researchers at CHOP published the final results of a key clinical trial of the gene therapy CASGEVY for the treatment of sickle cell disease.

Findings provide some of the first evidence of potential therapeutic targets for condition affecting thousands of patients with single ventricle congenital heart disease.

Check out the CDC’s new H5N1 webpage to stay updated on recent outbreaks in animals, and find out why the 2024-25 influenza vaccine will include three instead of four strains.

Researchers revealed new insights into the long-term effects of bronchopulmonary dysplasia (BPD), a chronic lung disease that primarily affects premature infants, on patient health.

Check out the types of info you can find in “The Pink Book,” “The Red Book,” “The Purple Book” and “The Yellow Book."

Read about a multicenter study that examined the efficacy of Paxlovid in fully vaccinated patients.

Part 1 of this two-part series takes a closer look at three areas that contribute to an individual’s reaction to a message: personal relationship to knowledge, feelings, and assessment of risk.